Free Trial
NASDAQ:MOR

MorphoSys (MOR) Stock Price, News & Analysis

MorphoSys logo
$18.96 0.00 (0.00%)
As of 08/7/2025

About MorphoSys Stock (NASDAQ:MOR)

Key Stats

Today's Range
$18.96
$18.96
50-Day Range
$18.96
$18.96
52-Week Range
$4.18
$19.50
Volume
N/A
Average Volume
1.02 million shs
Market Capitalization
$2.86 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MOR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MorphoSys and its competitors with MarketBeat's FREE daily newsletter.

MOR Stock News Headlines

The Coin That Could Define Trump’s Crypto Presidency
When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”
Novartis shutters MorphoSys sites, lays off staff
Novartis raises mid-term sales guidance
See More Headlines

MOR Stock Analysis - Frequently Asked Questions

MorphoSys' stock was trading at $18.96 at the beginning of 2025. Since then, MOR shares have increased by 0.0% and is now trading at $18.96.

MorphoSys (MOR) raised $200 million in an IPO on Thursday, April 19th 2018. The company issued 8,300,000 shares at a price of $24.12 per share. Goldman Sachs, J.P. Morgan and Leerink Partners acted as the underwriters for the IPO and Berenberg Capital Markets and JMP Securities were co-managers.

Shares of MOR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MorphoSys investors own include NVIDIA (NVDA), Broadcom (AVGO), Novo Nordisk A/S (NVO), e.l.f. Beauty (ELF), EMCOR Group (EME), Disc Medicine (IRON) and Builders FirstSource (BLDR).

Company Calendar

Today
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MOR
CIK
1340243
Employees
730
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.48)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$205.35 million
Net Margins
-226.79%
Pretax Margin
-225.77%
Return on Equity
-694.31%
Return on Assets
-22.55%

Debt

Debt-to-Equity Ratio
4.98
Current Ratio
1.38
Quick Ratio
1.38

Sales & Book Value

Annual Sales
$238.28 million
Price / Sales
11.99
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.35 per share
Price / Book
54.17

Miscellaneous

Outstanding Shares
150,621,000
Free Float
150,546,000
Market Cap
$2.86 billion
Optionable
Not Optionable
Beta
1.20

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:MOR) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners